PeptidePedia The community reference

Contributions of MoveRequestMio

User contributions·16 logged edits·page 1 of 1

Contributions by MoveRequestMio, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 488 edits includes activity predating the current log.

  1. 09:30, 18 Feb 2026 (diff | hist) Talk:Glucose-dependent insulinotropic polypeptide 674 +189 /* Requested move: → GIP */ new section
  2. 11:36, 11 Feb 2026 (diff | hist) Talk:Reconstitution calculator 811 +206 /* Requested move: → Peptide reconstitution calculator */ new section
  3. 12:03, 22 Jan 2026 (diff | hist) Talk:Glucagon-like peptide-1 811 +192 /* Requested move: → GLP-1 */ new section
  4. 10:00, 8 Nov 2025 (diff | hist) Talk:GLP-1 receptor agonist 811 +106 /* Requested move: → Glucagon-like peptide-1 receptor agonist */ new section
  5. 12:37, 15 Oct 2025 (diff | hist) Reconstitution calculator 8,662 +293 add the source for each stability figure in the table
  6. 11:41, 22 Apr 2025 (diff | hist) Talk:ChinaPeptides 400 +266 /* Which name should the article title use? */ new section
  7. 09:44, 17 Mar 2025 (diff | hist) TRIUMPH trial programme 4,014 +519 convert the endpoint list to a table for comparability
  8. 13:47, 12 Feb 2025 (diff | hist) Talk:Lyophilisation 1,033 +173 /* Requested move: → Lyophilization */ reply
  9. 09:40, 11 Feb 2025 (diff | hist) Talk:Lyophilisation 400 +355 /* Requested move: → Lyophilization */ new section
  10. 11:14, 9 Feb 2025 (diff | hist) Talk:Chinese Peptide Company 400 +310 /* Requested move: → Chinese Peptide Company Co., Ltd. */ new section
  11. 14:17, 25 Dec 2024 (diff | hist) Patent expiry and biosimilars 1,842 ±0 correct the description of the shortage-list mechanism
  12. 05:27, 11 Dec 2024 (diff | hist) SUSTAIN trial programme 4,169 +475 m convert the endpoint list to a table for comparability
  13. 09:00, 8 Nov 2024 (diff | hist) Contract development and manufacturing organisation 1,327 +1,327 N new article: supply and handling, expansion welcome
  14. 11:19, 8 Oct 2024 (diff | hist) Talk:Nantong Guangyuan Chemical 400 +210 /* Multiple trading names: which is the title? */ new section
  15. 06:22, 5 Sep 2024 (diff | hist) Retention time 1,620 +634 expand §Reporting on certificates
  16. 09:54, 25 Aug 2024 (diff | hist) Insulin syringe 2,340 +257 state that reconstituted material should not be frozen, with the source